Astellas Pharma Inc. (OTCMKTS:ALPMY) Sees Significant Growth in Short Interest
Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 138,700 shares, a growth of 87.2% from the May 15th total of 74,100 shares. Based on an average daily volume of 647,900 shares, […]
More Stories
Insider Selling: Zillow Group, Inc. (NASDAQ:ZG) COO Sells 10,000 Shares of Stock
Zillow Group, Inc. (NASDAQ:ZG – Get Free Report) COO Jun Choo sold 10,000 shares of the company’s stock in a...
Brilliant Acquisition Reports Unregistered Sales of Equity Securities; Nukleus Inc. Completes Transaction with Accredited Investor
Brilliant Acquisition (OTCMKTS:BRLIU) recently filed an 8-K form with the Securities and Exchange Commission reporting an unregistered sale of equity...
1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) Insider Sells $22,110.00 in Stock
1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS – Get Free Report) insider Arnold P. Leap sold 3,000 shares of the company’s stock in a...
Palo Alto Networks (NASDAQ:PANW) Earns Outperform Rating from Royal Bank of Canada
Royal Bank of Canada reiterated their outperform rating on shares of Palo Alto Networks (NASDAQ:PANW – Free Report) in a...
Cartica Acquisition (NASDAQ:CITEU) Announces Resignation of Kyle Ingvald Parent from Board of Directors
In a recent development, Cartica Acquisition Corp (the “Company”) disclosed in a Form 8-K filing with the Securities and Exchange...
Raymond James Trust N.A. Grows Stake in Analog Devices, Inc. (NASDAQ:ADI)
Raymond James Trust N.A. increased its holdings in shares of Analog Devices, Inc. (NASDAQ:ADI – Free Report) by 14.3% in...